Post by
MetzGER on Jan 06, 2022 3:08pm
2022
I am also very excited For the Year 2022. i am Sure we will See the 1$ Mark After Dermal injector commercialization. I See a lot of further potential with the ongoing fight with Shiseido. This could take Replicel Stock to 3-5$ this year. In the Next Weeks we will See some private Placements that the insiders like Andrew Schutte or Jamie Mackay will Load Up their shares. They Both Are recently Holding 6.000.000 Shares it is unbelievable... so much confidence in that stock. CEO Lee Buckler now has 790.000 options. They all will be fu.cking Rich. 2022 will be huge
Comment by
bluemoons20 on Jan 07, 2022 9:35pm
lets all hope that things start to unfold this year. With the current share structure, and insider holdings , the ability to really 'POP' is there as long as there is good news and they can garner some interest from outside investors. GLTA
Comment by
BellEnd on Jan 08, 2022 12:55am
This post has been removed in accordance with Community Policy
Comment by
BellEnd on Jan 08, 2022 7:57am
This post has been removed in accordance with Community Policy
Comment by
MetzGER on Jan 08, 2022 8:24am
Yes you Are right! Should be a lot of exciting News very soon!
Comment by
Ingiboy on Jan 09, 2022 11:57am
Once the testing at Monasterium is completed the big question is: Will Mainpointe/Replicel be able to apply for FDA Approval directly or will they first have to do further clinical (human) testing ?